The market speculates that following the FTC notice, several investors are pushing CVS Health to go for segment breakups.

In the high-stakes world of healthcare retail, CVS Health finds itself at a crossroads, navigating turbulent waters amid investor pressures and a stock price that seems to be on a downward spiral. ...

CVS Health (CVS) shares have been in the spotlight following reports that the healthcare services giant is considering separating its retail pharmacy and insurance units as it looks to improve prof...

CVS Health stock (NYSE: CVS) currently trades at $65 per share, 37% below its pre-inflation shock high of $102 seen in February 2022. In contrast, its peer – Walgreens stock – is down 78% over this...

Splitting up the company would face challenges, but there is no perfect solution to its struggles.

Glenview Capital Management, a hudge fund that has been subject of certain media reports that it was pushing CVS Health management to break up the healthcare giant, denies it is “pushing for a brea...

“While there's no guarantee it will happen, any company split would acknowledge that CVS can't be the integrated healthcare powerhouse it once thought,” one analyst said.

The job cuts will not affect front-line jobs in CVS stores, pharmacies or distribution centers, a spokesperson said.

CVS Health is slashing its headcount by 2,900, or 1% of its total workforce. The layoffs will largely focus on corporate positions, a spokesperson said.

CVS Health Corp (NYSE:CVS) is exploring options to split its retail and insurance divisions in response to investor pressure, according to a Reuters exclusive. The potential separation, which may l...

CVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter. The review has been ongoing for some time, said the people, but ...

Drugstore chain CVS Health Corp. in recent weeks has been reviewing its options as a company — among them a potential breakup — the Wall Street Journal reported on Monday.

CVS has faced consecutive guidance downgrades and a significant share price drop due to underperformance in its Medicare Advantage segment and rising costs. CEO Lynch's leadership is under scrutiny...

CVS Health (CVS) shares rose Monday on a report that major investor hedge fund Glenview Capital Management was planning to hold a meeting today with executives of the pharmacy and health care firm ...

Glenview Capital has amassed a sizable stake in CVS Health and plans to meet with the company's top executives to lay out its plan for value creation, according to people familiar with the matter. ...